Kim, Do Yeon <br/><br/>
A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.  [electronic resource] 

 -  Oncotarget  Mar 2016 
 - 14791-802 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.7443  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--drug therapy<br/>Cell Proliferation<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Glycogen Synthase Kinase 3--genetics<br/>Humans<br/>Mice<br/>Mice, Nude<br/>MicroRNAs--genetics<br/>Neoplastic Stem Cells--drug effects<br/>Phosphorylation<br/>Protein Kinase C--genetics<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--genetics